|
MRPL32 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89370000000167E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.101570E-01 |
| Normal-vs-Stage2 |
2.690000E-02 |
| Normal-vs-Stage3 |
3.16029999947176E-07 |
| Normal-vs-Stage4 |
4.16540000269805E-08 |
| Stage1-vs-Stage2 |
1.856810E-01 |
| Stage1-vs-Stage3 |
7.93350000000137E-05 |
| Stage1-vs-Stage4 |
1.61127999999122E-05 |
| Stage2-vs-Stage3 |
1.370560E-01 |
| Stage2-vs-Stage4 |
8.249800E-02 |
| Stage3-vs-Stage4 |
7.272400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0064999999978E-05 |
| Normal-vs-AfricanAmerican |
5.065800E-02 |
| Normal-vs-Asian |
3.174200E-01 |
| Caucasian-vs-AfricanAmerican |
8.673000E-01 |
| Caucasian-vs-Asian |
8.715000E-01 |
| AfricanAmerican-vs-Asian |
8.508400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.32640000000328E-06 |
| Normal-vs-Female |
1.699660E-02 |
| Male-vs-Female |
6.544000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.477900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.57409999999425E-05 |
| Normal-vs-Age(61-80Yrs) |
2.124200E-03 |
| Normal-vs-Age(81-100Yrs) |
3.711700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.545200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.431600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.870200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.398200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.222800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.524400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.351000E-01 |
| Normal-vs-Grade 2 |
2.419400E-01 |
| Normal-vs-Grade 3 |
4.33070000005475E-06 |
| Normal-vs-Grade 4 |
1.54769530524845E-11 |
| Grade 1-vs-Grade 2 |
7.489400E-01 |
| Grade 1-vs-Grade 3 |
1.186990E-01 |
| Grade 1-vs-Grade 4 |
3.843500E-03 |
| Grade 2-vs-Grade 3 |
4.574100E-04 |
| Grade 2-vs-Grade 4 |
1.15249998433598E-09 |
| Grade 3-vs-Grade 4 |
4.014000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.011200E-01 |
| Normal-vs-ccB subtype |
2.65609756411322E-11 |
| ccA subtype-vs-ccB subtype |
2.44249065417534E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.359220E-04 |
| Normal-vs-N1 |
9.66830004944796E-09 |
| N0-vs-N1 |
8.163800E-03 |
|
|
